← All stocks

Silexion Therapeutics Corp

SLXN No buying or selling
CIK 0002022416 #5577 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

9 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Levin Ilan
Director
456,970
$621.48K
+3,550%
Noy Shlomo
Director
25,399
$34.54K
+72.5%
Lushi Avner
Director
25,399
$34.54K
+72.5%
Hadar Ilan
Chairman and CEO
16,547
$22.50K
Horenshtein Hadar Mirit
CFO and Secretary
12,515
$17.02K
Alon Ruth
Director
10,228
$13.91K
+2,882%
Abramov Dror Yosef
Director
10,180
$13.84K
+3,351%
Shirvan Mitchell
CSO and CDO
8,789
$11.95K
Peled Amnon
Director
8,237
$11.20K

No percentages here. This company's share count has moved by a factor of 11,501.0 over the window, from 731,642 to 8,414,615,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 31 Dec 2025